Complement activation by LDL-apheresis using dextran sulphate. 1995

M Pascual, and E Blanc, and J A Schifferli

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D001781 Blood Component Removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor. Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D016264 Dextran Sulfate Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4-POSITIVE T-LYMPHOCYTES. It is commonly used as both an experimental and clinical laboratory reagent and has been investigated for use as an antiviral agent, in the treatment of hypolipidemia, and for the prevention of free radical damage, among other applications. Sodium Dextran Sulfate,Dextran Sulfate Sodium,Dextran Sulfate, Sodium,Sulfate Sodium, Dextran,Sulfate, Dextran,Sulfate, Sodium Dextran

Related Publications

M Pascual, and E Blanc, and J A Schifferli
December 1992, Lancet (London, England),
M Pascual, and E Blanc, and J A Schifferli
October 1992, Lancet (London, England),
M Pascual, and E Blanc, and J A Schifferli
January 1993, Lancet (London, England),
M Pascual, and E Blanc, and J A Schifferli
July 2012, Acta biomaterialia,
M Pascual, and E Blanc, and J A Schifferli
June 1991, European journal of clinical investigation,
M Pascual, and E Blanc, and J A Schifferli
August 1992, Infusionstherapie und Transfusionsmedizin,
M Pascual, and E Blanc, and J A Schifferli
January 1988, Beitrage zur Infusionstherapie = Contributions to infusion therapy,
M Pascual, and E Blanc, and J A Schifferli
June 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
M Pascual, and E Blanc, and J A Schifferli
July 1992, Angiology,
M Pascual, and E Blanc, and J A Schifferli
June 1956, British journal of pharmacology and chemotherapy,
Copied contents to your clipboard!